Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLoans and Notes ReceivablesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Rent ExpenseShares IssuedShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

National Healthcare (NHC) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $630.5 million.

  • National Healthcare's Accumulated Depreciation & Amortization rose 564.92% to $630.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $630.5 million, marking a year-over-year increase of 564.92%. This contributed to the annual value of $597.4 million for FY2024, which is 179.25% down from last year.
  • National Healthcare's Accumulated Depreciation & Amortization amounted to $630.5 million in Q3 2025, which was up 564.92% from $619.4 million recorded in Q2 2025.
  • Over the past 5 years, National Healthcare's Accumulated Depreciation & Amortization peaked at $630.5 million during Q3 2025, and registered a low of $520.3 million during Q1 2021.
  • Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $584.7 million (2023), whereas its average is $578.7 million.
  • As far as peak fluctuations go, National Healthcare's Accumulated Depreciation & Amortization soared by 698.69% in 2023, and later tumbled by 179.25% in 2024.
  • Over the past 5 years, National Healthcare's Accumulated Depreciation & Amortization (Quarter) stood at $543.3 million in 2021, then increased by 5.77% to $574.7 million in 2022, then rose by 5.86% to $608.4 million in 2023, then dropped by 1.79% to $597.4 million in 2024, then grew by 5.53% to $630.5 million in 2025.
  • Its last three reported values are $630.5 million in Q3 2025, $619.4 million for Q2 2025, and $608.4 million during Q1 2025.